Cleared Traditional

K911834 - OPUS(R) ROZO
(FDA 510(k) Clearance)

Aug 1991
Decision
109d
Days
Class 2
Risk

K911834 is an FDA 510(k) clearance for the OPUS(R) ROZO. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (Class II - Special Controls, product code LGD).

Submitted by Pb Diagnostic Systems, Inc. (Westwood, US). The FDA issued a Cleared decision on August 12, 1991, 109 days after receiving the submission on April 25, 1991.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.3780.

Submission Details

510(k) Number K911834 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 1991
Decision Date August 12, 1991
Days to Decision 109 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code LGD — Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3780

Similar Devices — LGD Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii

All 105
Access Toxo IgG
K242022 · Beckman Coulter, Inc. · Mar 2025
Access Toxo IgM II
K242095 · Beckman Coulter, Inc. · Oct 2024
Alinity i Toxo IgM
K233932 · Abbott Laboratories · Aug 2024
ARCHITECT Toxo IgG
K210596 · Abbott Laboratories · May 2022
Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl
K162678 · Roche Diagnostics · Jun 2017
ADVIA Centaur Toxoplasma M (Toxo M)
K142826 · Siemens Healthcare Diagnostics, Inc. · Dec 2015